The French National Agency for Medicines and Health Products Safety (ANSM) has just announced a ban, effective June 3, 2024, on several cannabinoid chemical substances, including THCP. This decision raises a number of questions and sparks various debates among industry professionals, consumers, and regulatory authorities.
What is THCP?
THCP (tetrahydrocannabiphorol) is a cannabinoid recently discovered by a team of Italian researchers that shares a chemical structure similar to that of THC ( tetrahydrocannabinol ), the main psychoactive compound in cannabis. Like THC, THCP acts on the CB1 and CB2 receptors of the human endocannabinoid system.
THCP production
The production of THCP (tetrahydrocannabiphorol) is an emerging area of cannabinoid research , relying on advanced extraction and chemical synthesis techniques. As a recently discovered compound, its presence in cannabis plants is in very small quantities, making direct extraction difficult and expensive.
To isolate THCP, scientists use sophisticated methods such as high-performance liquid chromatography (HPLC) and mass spectrometry, allowing them to separate and identify this specific cannabinoid among the many others present in cannabis. Alternatively, chemical synthesis in the laboratory is a promising way to produce THCP in sufficient quantities. This approach involves chemically modifying THC molecules to obtain THCP, a complex process requiring expertise in organic chemistry.
Does THCP pose a risk to consumer health?
No major incidents related to THCP have been reported to date. However, no scientific research has proven the absence of danger from this substance. The only contraindications to its use are its prohibition for minors, pregnant women, and breastfeeding mothers. It was also recommended to consume small doses to observe the body's reaction.
Why will THCP be banned in France on June 3, 2024?
To understand this ban, it is essential to know about THCP. This recently discovered cannabinoid has a chemical structure similar to THC, the main psychoactive compound in cannabis, but with potentially higher potency. User reports have described serious side effects such as vomiting, seizures, and anxiety, prompting the ANSM (French National Agency for Medicines and Health Products Safety) to take this preventative measure.
The consequences of the THCP ban
Consumer reactions
Among consumers, the THCP ban has sparked both frustration and confusion. Some regular users of CBD and its derivatives have expressed their disappointment with the reduced availability of products and the ban itself.
Impact on the cannabis industry
For the cannabis industry, the ban on THCP represents a major challenge. These cannabinoids, sold in various forms such as oils ,resins, and flowers, were gaining popularity in the market. Their prohibition could lead to a decrease in revenue for producers and retailers who had specialized in these products. Furthermore, investments in research and development dedicated to these substances may not be recouped, resulting in significant financial losses.
The consequences for CBD shops
The ban on THCP will profoundly affect stores specializing in the sale of cannabinoid products. These retailers will have to remove all products containing THCP from their shelves, resulting in a significant reduction in their offerings.
Therefore, it is important to emphasize that the ban on THCP in France by the National Agency for the Safety of Medicines and Health Products (ANSM) is primarily motivated by the potential risk of addiction and undesirable side effects. This decision has had a significant impact on both retailers and consumers. While some specialized stores are already turning to other legal alternatives to THCP, the future of cannabis legislation in France raises legitimate questions.
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.
